TAVR and COVID-19: Latest Society Guidance and Experiences From the US and Canada Enduring

Learning Objectives

At the conclusion of the course, participants should able to:
1. Identify essential vs. non-essential procedures in TAVR
2. Perform risk stratification in patients who may need TAVR
3. Implement team-wide infection control protocols in the TAVR clinic

Faculty

	Ehtisham Mahmud, MD, FACC, FSCAI President, Society for Cardiovascular Angiography and Interventions Edith and William Perlman Chair in Cardiology Professor and Division Chief, Cardiovascular Medicine Executive Director, UCSD Cardiovascular Institute-Medicine University of California, San Diego	Chair
	David A Wood, MD, FRCPC, FACC, FSCAI President, Canadian Association Interventional Cardiology Professor, University of British Columbia Director, Centre for Cardiovascular Innovation Director, VGH Cardiac Catheterization Laboratory Incoming Division Head, VGH and UBC Hospital	Chair
	Kendra J. Grubb, MD, MHA, FACC Surgical Director, Emory Structural Heart and Valve Center Emory University	Faculty
	Kim Guibone, DNP, APRN Structural Heart Lead Nurse Practitioner Beth Israel Deaconess Medical Center	Faculty
	Pinak Bipin Shah, MD, FACC, FSCAI Director of the Cardiac Catheterization Laboratory Director of the Interventional Cardiology Training Program Brigham and Women's Hospital in Boston	Faculty
	Molly Szerlip, MD, FACC, FSCAI Medical Director of the Inpatient and Outpatient Valve Service Program Program Director for the Structural Fellowship Baylor Scott & White/The Heart Hospital	Faculty

Agenda

Welcome and Introductions
Defining Essential vs. Non-essential Procedures in TAVR
How Do You Stratify Risk in TAVR Patients?
Guidance to Valve Coordinators and Structural Heart Teams on Operating a TAVR Clinic in the Age of COVID-19.
Moderated Q&A and Panel Discussion
Take-Home Messages

Accreditation & Designation Statements

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Society for Cardiovascular Angiography and Interventions designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To obtain credit please complete the evaluation in its entirety.

Acknowledgment of Commercial Support

This activity is supported by unrestricted educational grants from: Edwards Lifesciences and Medtronic.

No in-kind commercial support was received.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered